RE: As of the where Sclp stands today with their Compounds.25 Jun 2020 14:02
Hi Cars,
Yes good post.
Would say the changes in the last few years in pharma have to an extent streamlined this type of decision making.
The way it tends to work is a Company's has a strategic plan with a number of areas assigned a particular priority and often there decision to partner with someone tends to be made as much by strategic fit however good the science.
That is why the improved sentiment re cancer Vax really plays in SCLP favour and of course the Avidmab deals are so good potential